← All organizations

Enliven Therapeutics

For profitWebsite ↗

Also known as: Enliven Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jan 23, 2025

Timeline

2010s

Jan 1, 2019
Enliven Therapeutics— Founded

2020s

Oct 14, 2022
Imara, Inc.— Acquired

Drugs by trial phase (12 distinct, 10 trials)

Phase 2 (0 own, 1 via acquisition)

Tovinontrine

Phase 1 (11 own, 0 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Imara, Inc.

Recent trials (5)

NCT06787144Lead sponsorPhase 1Jan 23, 2025
NCT06787144OfficialPhase 1Jan 23, 2025
NCT06328738Lead sponsorPhase 1May 30, 2024
NCT05650879Lead sponsorPhase 1Mar 31, 2023
NCT05304377Lead sponsorPhase 1May 22, 2022

Details

Founded: Denver, CO, US Jan 1, 2019
Last known activity: Jan 23, 2025